News Feature Channel: Immunology

Immunotherapy May Boost KRAS-Targeted Therapy in Pancreatic Cancer

Perelman School of Medicine at the University of Pennsylvania — Fri, 14 Mar 2025 20:40:54 EST

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. The study was published in Cancer Discovery by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center.

Measles Resurgence Q & A: Epidemiologist Explains Why Cases Are Surging and How to Stop the Spread

Virginia Tech — Thu, 13 Mar 2025 20:55:58 EST

Virginia Tech infectious disease epidemiologist Lisa M. Lee explains why new measles cases are being reported around the country, not just in Texas, despite the illness being declared eliminated in the U.S. in the early 2000s due to rigorous vaccine uptake. What factors have contributed to the recent measles outbreak, and why is it spreading so quickly? "Measles is back because of falling vaccination rates.

Johns Hopkins Medicine Experts Available to Discuss Measles Prevention

Johns Hopkins Medicine — Thu, 13 Mar 2025 20:30:07 EST

Johns Hopkins Children's Center pediatric infectious diseases specialists Aaron Milstone, M.D., M.H.S., and Erica Prochaska, M.D., M.H.S., M.H.S., are available to discuss the following topics related to measles.

The Pandemic: A Pause in Research or a Springboard?

Universite de Montreal — Thu, 13 Mar 2025 17:20:44 EST

Five years later, three UdeM researchers reflect on the impact of the global COVID-19 health crisis on their work.

Breakthrough Study Led by CHLA Neurologists Links Blood-Brain Barrier Dysfunction and Inflammation With Down Syndrome Regression Disorder

Children's Hospital Los Angeles — Wed, 12 Mar 2025 20:10:13 EST

A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children's Hospital Los Angeles, shows evidence of dysfunction of the blood-brain barrier and inflammation in the central nervous system in individuals with Down syndrome Regression Disorder (DSRD).The new study, "Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder," was published in the Annals of Clinical and Translational Neurology on Feb.

FASEB Announces Inaugural Cohort of Fellows for the Future Program

Federation of American Societies for Experimental Biology (FASEB) — Wed, 12 Mar 2025 19:35:37 EST

FASEB welcomes the inaugural Fellows for the Future cohort, supporting early-career researchers from historically excluded groups who are dedicated to promoting inclusion in scientific societies.

Expert Briefing - Vaccines: Purpose, Effectiveness, and Safety

Johns Hopkins Bloomberg School of Public Health — Wed, 12 Mar 2025 08:00:02 EST

Epidemiologist: Spring Break, Particularly in Texas, Could Intensify Spread of Measles

University of Delaware — Tue, 11 Mar 2025 20:55:34 EST

Drug Building Blocks Pave Path to New Sepsis Treatments

Sanford Burnham Prebys — Tue, 11 Mar 2025 20:25:14 EST

The immune system typically can ramp up the body's defenses to clear out an invading threat without issue. Glitches can happen, however, with sepsis occurring when the mustered army of cells also attacks the body's own tissues and organs as if they were enemy combatants.

11 Things You Need to Know About Measles

Corewell Health — Tue, 11 Mar 2025 20:15:11 EST

11 things you need to know about measles

Discovery of Mosquito Molecular Mechanism Opens Door to New Antimalaria Strategies

Johns Hopkins Bloomberg School of Public Health — Tue, 11 Mar 2025 20:15:06 EST

A molecular quality-control system in Anopheles mosquitoes--the species responsible for most of the world's malaria cases--is a promising target for future malaria-control strategies, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

Ats Breathe Easy - One Size Does Not Fit All: Increasing Vaccine Access in Adults

American Thoracic Society (ATS) — Tue, 11 Mar 2025 19:50:17 EST

ATS Breathe Easy - One Size Does Not Fit All: Increasing Vaccine Access in Adults

Meningococcal Vaccine Found to be Safe and Effective for Infants in Sub-Saharan Africa

University of Maryland School of Medicine — Tue, 11 Mar 2025 19:30:00 EST

University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age.

JMU Expert Available to Speak About Measles, Vaccines

James Madison University — Tue, 11 Mar 2025 09:35:40 EST

Inhaled COVID Vaccine Begins Recruitment for Phase-2 Human Trials

McMaster University — Mon, 10 Mar 2025 18:45:55 EST

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

Wayne State University Experts Available to Offer Insights on Measles Outbreak

Wayne State University Division of Research — Fri, 07 Mar 2025 18:05:50 EST

The Medical Minute: Measles Makes a Comeback. Your Questions Answered

Penn State Health — Wed, 05 Mar 2025 19:45:44 EST

Measles cases are rising in the U.S., with Pennsylvania reporting its first case this year. A Penn State Health pediatric infectious disease physician answers your questions about the highly contagious virus and why vaccination remains the best defense.

Neurosurgeon Raises NIH Funding Concerns in Key Letter

UC San Diego Health — Wed, 05 Mar 2025 19:10:57 EST

NIH Provides Critical Funding for Pediatric Clinical Trials in Diseases Not Prioritized by Industry, Study Shows

Ann and Robert H. Lurie Children's Hospital of Chicago — Tue, 04 Mar 2025 16:45:58 EST

"We observed that NIH funded key research areas that are less often prioritized by industry, and this is critical for establishing new treatments that children need," said lead author Ansh...

New HIV Vaccine Candidate Discovered with Help From Argonne's Advanced Photon Source

Argonne National Laboratory — Tue, 04 Mar 2025 16:40:07 EST

Protein crystallization at the SER-CAT beamline at Argonne's Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.